Published in FASEB J on November 24, 2010
New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors. Purinergic Signal (2012) 1.04
Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats. J Neurosurg (2012) 0.91
Thymosin β 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK. Glia (2012) 0.89
Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice. Neurobiol Dis (2012) 0.86
β-thymosins and hemocyte homeostasis in a crustacean. PLoS One (2013) 0.80
Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells. Stem Cell Res Ther (2015) 0.80
Retracted Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and PH domain and leucine-rich repeat phosphatase cross-talk (PHLPP) in cancer cells and in transforming growth factor β-activated stem cells. J Biol Chem (2014) 0.79
Molecular and Physiological Characterization of Two Novel Multirepeat β-Thymosins from Silkworm, Bombyx mori. PLoS One (2015) 0.77
A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing. Drug Des Devel Ther (2013) 0.76
Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs. Front Pharmacol (2016) 0.75
Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits. Drug Des Devel Ther (2015) 0.75
The Hidden Function of Vitamin D. Open Access Maced J Med Sci (2016) 0.75
Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics (2004) 2.00
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin. Proc Natl Acad Sci U S A (2012) 1.98
Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation. J Proteome Res (2006) 1.82
Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1. Cancer Biol Ther (2002) 1.67
Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins. J Cell Biol (2005) 1.59
Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem (2004) 1.58
Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines. Cancer Biol Ther (2004) 1.42
Cancer biomarkers: knowing the present and predicting the future. Future Oncol (2005) 1.29
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res (2013) 1.24
Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proc Natl Acad Sci U S A (2010) 1.23
X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22
Crystal structure of Bacillus stearothermophilus UvrA provides insight into ATP-modulated dimerization, UvrB interaction, and DNA binding. Mol Cell (2007) 1.21
DEF-1/ASAP1 is a GTPase-activating protein (GAP) for ARF1 that enhances cell motility through a GAP-dependent mechanism. J Biol Chem (2001) 1.13
Synthesis and structure of duplex DNA containing the genotoxic nucleobase lesion N7-methylguanine. J Am Chem Soc (2008) 1.09
Architecture of the herpes simplex virus major capsid protein derived from structural bioinformatics. J Mol Biol (2003) 1.05
Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res (2009) 1.04
Crystal structures of the vaccinia virus polyadenylate polymerase heterodimer: insights into ATP selectivity and processivity. Mol Cell (2006) 1.01
Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Mol Cancer Res (2011) 1.00
Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism. J Cell Sci (2006) 0.99
Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. BMC Cancer (2014) 0.98
Assessing enzyme activities using stable isotope labeling and mass spectrometry. Mol Cell Proteomics (2007) 0.98
Enforced presentation of an extrahelical guanine to the lesion recognition pocket of human 8-oxoguanine glycosylase, hOGG1. J Biol Chem (2012) 0.95
Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential. Clin Exp Metastasis (2012) 0.93
Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci Rep (2013) 0.91
Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. ACS Nano (2010) 0.90
Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS One (2012) 0.89
Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J Biol Chem (2003) 0.89
Collagen XXIII expression is associated with prostate cancer recurrence and distant metastases. Clin Cancer Res (2007) 0.89
Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. Exp Cell Res (2004) 0.88
Biomaterials for mRNA delivery. Biomater Sci (2015) 0.87
Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer. Clin Biochem (2005) 0.86
Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev (2010) 0.86
Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J Proteome Res (2010) 0.85
Proteomics in tumor progression and metastasis. Ann N Y Acad Sci (2005) 0.84
Computational and biochemical identification of a nuclear pore complex binding site on the nuclear transport carrier NTF2. J Mol Biol (2004) 0.81
The Contribution of Angiogenesis to the Process of Metastasis. Cancer J (2015) 0.80
Thymosin beta-NB is the human isoform of rat thymosin beta15. Ann N Y Acad Sci (2007) 0.79
Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1. Genes Chromosomes Cancer (2009) 0.79
Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids (2011) 0.78
Use of thymosin beta15 as a urinary biomarker in human prostate cancer. Prostate (2005) 0.75
Cancer. The silence of the genes. Nature (2002) 0.75
Meeting report: innovations in prostate cancer research. Cancer Res (2008) 0.75
Ubiquitin-independent degradation and its implication in cancer. Future Oncol (2005) 0.75